Back to Studies
IMPAACT 2024
Phase I/II Dose Finding and Safety Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Infants, Children and Adolescents
Study Status
In Development
Locality
US & Non-US
DAIDS Number
38747
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...